News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Ho Robert
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/08/2023 |
4
| Ho Robert (CFO) has filed a Form 4 on Third Harmonic Bio, Inc.
Txns:
| Disposed/sold 367,955 options to buy
@ $9.22, valued at
$3.4M
Granted 367,955 options to buy
@ $4.2, valued at
$1.5M
Disposed/sold 95,000 options to buy
@ $18.4, valued at
$1.7M
Granted 95,000 options to buy
@ $4.2, valued at
$399k
Granted 136,000 options to buy
@ $4.2, valued at
$571.2k
|
|
10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/14/2022 |
3
| Ho Robert (CFO) has filed a Form 3 on Third Harmonic Bio, Inc. |
02/02/2022 |
4
| Ho Robert (CFO) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns:
| Granted 70,000 restricted stock units
@ $0 |
|
03/18/2021 |
4
| Ho Robert (CFO) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns:
| Sold 6,497 shares
@ $11.0137, valued at
$71.6k
Exercised 25,000 restricted stock units
@ $0 |
|
08/12/2020 |
4
| Ho Robert (CFO) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns:
| Granted 90,000 options to buy
@ $12, valued at
$1.1M
|
|
03/16/2020 |
4
| Ho Robert (CFO) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns:
| Granted 75,000 restricted stock units
@ $0 Granted 200,000 options to buy
@ $6.44, valued at
$1.3M
|
|
03/16/2020 |
3
| Ho Robert (CFO) has filed a Form 3 on Neoleukin Therapeutics, Inc. |
|
|